Matrix Innovation Inc., a word leader in the development of speciality resins signed a licence agreement with PCAS BioMatrix, a division of PCAS. Under the terms of this agreement, PCAS BioMatrix acquires the rights to manufacture and commercialize the ChemMatrix resin, a 100% Polyethylene Glycol polymer developed and patented by Matrix Innovation. See press release
For more information on the ChemMatrix resin technology, please visit
www.pcasBioMatrix.com
|